Background: In Canada, published outcome data for COVID-19 come largely from the first 2
waves of the pandemic. We examined changes in demographics and 30-day outcomes after …

Rationale: Even though idiopathic pulmonary fibrosis (IPF) is a disease with high morbidity
and mortality and no cure, palliative care is rarely implemented, leading to high symptom …

Importance With the emergence of more transmissible SARS-CoV-2 variants of concern (VOC),
there is an urgent need for evidence about disease severity and the health care impacts …

Aims Heart failure with mildly reduced ejection fraction (HFmrEF) is associated with a
favourable prognosis compared with heart failure (HF) with reduced ejection fraction (EF). We …

The initial two-dose vaccine series and subsequent booster vaccine doses have been
effective in modulating SARS-CoV-2 disease severity and death but do not completely prevent …

Background Prior studies of COVID-19 cardiovascular sequelae include diagnoses made
within 4 weeks, but the World Health Organization definition for “postacute phase” is >3 months…

Background Quadruple therapy is recommended for the management of patients with heart
failure (HF) and reduced ejection fraction (HFrEF). In order to provide background and …

Background Composite endpoints for estimating treatment efficacy are routinely used in
several therapeutic areas and have become complex in the number and types of component …

BACKGROUND: Tourniquets are effective tools to manage life-threatening extremity
hemorrhage. Commercial devices are recommended over improvised ones; however, mass …

A large part of lands under maize cultivation have various degrees of salinity. To study the
effects of spraying time of cytokinin and auxin regulators on some characteristics of grain …